Pre-IPO investors cash in on Mindray before lockup expiry
The $240 million sale is priced at a 2.5% discount and comes as the stock is up 86% since the September listing.
Existing shareholders have sold $240.8 million worth of Mindray Medical International shares through a fully marketed transaction that was priced after US markets closed on Tuesday January 30.
The sale, which came only four months after the company completed its initial public offering on the New York Stock Exchange, was priced at $24.50, which marked a discount of 2.5% to TuesdayÆs close of $25.12. Observers described this as ôquite tightö given that the share price had risen in each...
To continue reading, please login or register for free